Sarepta; Elevidys; Biogen; Eisai; Roivant Sciences; GSK; Pfizer; Leqembi; RVT-3101; Abrysvo; Arexvy

Sarepta; Elevidys; Biogen; Eisai; Roivant Sciences; GSK; Pfizer; Leqembi; RVT-3101; Abrysvo; Arexvy

Today in FirstWord Pharma 's Industry News newsletter ???, we cover:

? Sarepta gets FDA nod for DMD gene therapy Elevidys

?? Medicare gives more details on reimbursement for new Alzheimer's drugs

?? Roivant shares climb on longer-term ulcerative colitis drug results

?? EFPIA calls for revisions to EU pharmaceutical legislation

?? US panel recommends older adults "may" receive RSV vaccine

?? Get FirstWord's Industry News newsletter and stay ahead of the curve with the?#pharma?industry's top news and insights delivered to you ?? https://firstwordpharma.com/register

#pharmaceuticals #biotechnology #news #insights

要查看或添加评论,请登录

FirstWord Pharma的更多文章

社区洞察

其他会员也浏览了